Cervical Cancer Vaccines Could Be Cost-Effective For Developing Countries, Researchers Say
Cervical Cancer Vaccines Could Be Cost-Effective For Developing Countries, Researchers Say
Cervical cancer vaccines from Merck and GlaxoSmithKline could be cost-effective if subsidies or new prices are created so developing countries can afford them, researchers said Thursday at the World Cancer Congress in Geneva, Reuters reports.
What next?
Posting Komentar